Thanks Imran.
I've been looking at KME of late. They seem to provide some value if they can replicate the 2H14 performance of NPAT=$589K for 1H15. Do you think this is realistic? Is there any seasonality at play?
New revenue initiative, page-2
Add KME (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
-0.010(2.94%) |
Mkt cap ! $18.75M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 33.5¢ | 32.5¢ | $3.86K | 11.82K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 33176 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 2020 | 1 |
View Market Depth
| Last trade - 15.44pm 29/07/2024 (20 minute delay) ? |
| KME (ASX) Chart |